STOCK TITAN

CAVITATION TECHS (CVAT) Stock News

CVAT OTC

Cavitation Technologies, Inc. reports developments around its fluid-processing technology business and its expansion into water treatment and digital payment infrastructure. The company designs and manufactures flow-through nano-technology systems for fluid processing applications, including Nano Reactor® systems and Cavitation Non-Thermal Plasma™ technology for water treatment, remediation, PFAS removal, and other industrial uses.

Recurring updates include pilot and partnership activity for cavitation-based systems, subsidiary developments at XYRA Corp., license agreements and market expansion for remittances, fintech, and crypto-asset transactions, and governance changes. CVAT announcements also reference shareholder voting matters, capital-structure disclosures, material agreements, and board or advisory roles tied to its operating subsidiaries and technology commercialization efforts.

Rhea-AI Summary

Cavitation Technologies (CVAT) signed definitive agreements with BrightFlixx Finance (Luxembourg) for proposed cash tender offers covering all outstanding common shares.

The $42 million aggregate proposed consideration consists of $35 million for CVAT and $7 million for Alchemy Beverages, subject to the agreements' terms and conditions. The agreements replace terminated tender offer agreements with European Guarantee Services. Material terms are substantially similar, and Bright Wealth Banking remains the financing institution. The tender offers have not commenced. BrightFlixx expects to launch them and make required SEC filings; CVAT plans to file a Form 8-K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Cavitation Technologies (OTCQB: CVAT) is linked to a pair of cash tender offers by European Guarantee Services S.à.r.l. (“EGS”). EGS executed a definitive tender offer agreement with Alchemy Beverages to acquire all Alchemy common shares for $7 million in cash, less certain indebtedness and accrued liabilities.

EGS previously signed a separate definitive agreement on August 17, 2026, to seek all outstanding shares of CVAT common stock for $35 million in cash, also less certain indebtedness and accrued liabilities. The aggregate cash consideration for the two transactions is $42 million, and completion of each tender offer is a condition to closing the other. EGS is expected to commence the Alchemy offer within ten business days of the August 19, 2026 agreement by distributing offer documents to Alchemy shareholders. Alchemy’s board plans to obtain an independent fairness opinion before issuing its recommendation, and investors will be able to access related offer materials and filings, when available, through the SEC’s website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.36%
Tags
none
-
Rhea-AI Summary

Cavitation Technologies (OTCQB: CVAT) signed a definitive tender offer agreement on August 14, 2026 with European Guarantee Services S.à.r.l. (EGS). EGS will seek to acquire all outstanding CVAT common shares for a total cash consideration of $35 million, less certain company indebtedness and accrued liabilities, via a tender offer conducted under Regulation 14D of the U.S. Securities Exchange Act.

CVAT also anticipates EGS will, within five business days, enter a separate definitive tender offer agreement to acquire all shares of Alchemy Beverages for $7 million (less ABI indebtedness and liabilities). CVAT owns approximately 17% of Alchemy. The combined transactions contemplate aggregate cash consideration of $42 million. CVAT plans to file a Form 8-K within three business days and, after EGS commences the offer and files Schedule TO, will submit a Schedule 14D-9 recommendation statement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.15%
Tags
none
Rhea-AI Summary

Cavitation Technologies (OTCQB: CVAT) confirmed receipt of $45 million documentary proof of funds from European Guarantee Services S.à.r.l. (EGS) for a previously disclosed Letter of Intent to acquire 100% of the company at an estimated valuation of $40–$42 million.

The proof of funds fully covers the proposed all-cash transaction and indicates potential additional financing capacity. Next steps include obtaining a fairness opinion, shareholder and regulatory approvals, and in-person meetings in Switzerland April 13–18 to advance transaction execution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.6%
Tags
-
Rhea-AI Summary

Cavitation Technologies (OTCQB: CVAT) received a Letter of Intent from European Guarantee Services on March 30, 2026 proposing an all-cash acquisition of 100% of CVAT and affiliates for a valuation of $40–$42 million (≈$0.13 per share fully diluted).

The LOI is subject to due diligence, a definitive agreement, a Board fairness opinion, shareholder approval under Nevada law, U.S. regulatory clearances (potentially CFIUS), proof of funds within 10 days, and a 60-day exclusivity period. The LOI expires August 1, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
70.63%
Tags
-
Rhea-AI Summary

XYRA Corp. (OTCQB: CVAT) appointed fintech leader Maria Medvedeva as Chairwoman of the Board of Advisors to guide expansion of its AI-driven, quantum-secure payments network across the Americas.

Medvedeva brings 25+ years in payments, senior roles at Mastercard and Skyro, industry awards, and will support XYRA as it targets initial revenue in H2 2026 and seeks institutional capital to scale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags
none
Rhea-AI Summary

Cavitation Technologies (OTCQB: CVAT) reported 2025 milestones and a strategic outlook for 2026. Key developments include completion and pilot testing of Cavitation Non-Thermal Plasma™ (CNTP™) at 20 GPM, formation of subsidiary XYRA Corp., entry into immersion cooling and digital payments, and ABI audit/commercial plans.

XYRA targets an institutional raise at an approximate $15M valuation and may seek up to $100M in H2 2026; CTi plans continued R&D, university collaborations, and potential strategic alternatives for subsidiary holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7%
Tags
none
-
Rhea-AI Summary

XYRA Corp (OTCQB: CVAT) is prioritizing Honduras as a core remittance and digital-transfers market, citing Honduras' $9.5 billion in 2024 remittances (over 85% from the United States).

The company announced a third-party license agreement on December 1 to support real-time remittance and cryptocurrency transactions with instant fiat conversion, and in November appointed José Rodolfo Zelaya as Strategic Advisor to provide regional insight.

XYRA says its tokenization will operate as back-end infrastructure to comply with Honduran rules requiring payouts in local fiat, and it highlights goals of real-time payouts, multi-currency and multi-rail support, lower costs, and integration into its AI-driven, quantum-secure ecosystem.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.99%
Tags
none
-
Rhea-AI Summary

XYRA Corp. (OTCQB: CVAT) announced a license agreement enabling its platform to accept and process digital assets in real time, including USDC, Bitcoin, Ethereum, and Tether, with instant conversion to U.S. dollars or local fiat. The release highlights XYRA’s goal of instant settlements versus typical 2–5 day bank settlement and high remittance fees (6–8%), and describes integration of the licensed capability into XYRA’s proprietary, AI-driven, quantum-secure payment infrastructure.

The announcement notes this step follows a strategic partnership with Bitcoin Bancorp to integrate XYRA technology into a licensed ATM network across North America, strengthening XYRA’s early operational footprint while development of full platform continues.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.74%
Tags
crypto
Rhea-AI Summary

XYRA Corp (OTCQB: CVAT) appointed José Rodolfo Zelaya, former four-term Congressman and Minister of Budget and Planning of Honduras, as Strategic Advisor to lead business development and government partnerships across Latin America, announced Nov 6, 2025.

Mr. Zelaya brings more than three decades of public policy, investment strategy, and infrastructure experience to support XYRA’s expansion of its AI-driven, quantum-secure payment network that unites remittances, fintech, and crypto assets. The release cites a $161 billion 2024 cross-border remittance market in Latin America and the Caribbean as a target opportunity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.65%
Tags
none

FAQ

What is the current stock price of CAVITATION TECHS (CVAT)?

CAVITATION TECHS (CVAT) last closed at $0.03.

What is the market cap of CAVITATION TECHS (CVAT)?

The market cap of CAVITATION TECHS (CVAT) is approximately $9.7M.